274 related articles for article (PubMed ID: 31278580)
1. Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.
Marcon J; Graser A; Horst D; Casuscelli J; Spek A; Stief CG; Reiser MF; Rübenthaler J; Buchner A; Staehler M
Eur Radiol; 2020 Jan; 30(1):1-10. PubMed ID: 31278580
[TBL] [Abstract][Full Text] [Related]
2. Quantitative iodine content threshold for discrimination of renal cell carcinomas using rapid kV-switching dual-energy CT.
Zarzour JG; Milner D; Valentin R; Jackson BE; Gordetsky J; West J; Rais-Bahrami S; Morgan DE
Abdom Radiol (NY); 2017 Mar; 42(3):727-734. PubMed ID: 27847998
[TBL] [Abstract][Full Text] [Related]
3. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
[TBL] [Abstract][Full Text] [Related]
5. Effect of spectral CT on tumor microvascular angiogenesis in renal cell carcinoma.
Zhang B; Wu Q; Qiu X; Ding X; Wang J; Li J; Sun P; Hu X
BMC Cancer; 2021 Jul; 21(1):874. PubMed ID: 34330234
[TBL] [Abstract][Full Text] [Related]
6. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study.
Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G
Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309
[TBL] [Abstract][Full Text] [Related]
7. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
[TBL] [Abstract][Full Text] [Related]
8. Normalized Dual-Energy Iodine Ratio Best Differentiates Renal Cell Carcinoma Subtypes Among Quantitative Imaging Biomarkers From Perfusion CT and Dual-Energy CT.
Manoharan D; Netaji A; Diwan K; Sharma S
AJR Am J Roentgenol; 2020 Dec; 215(6):1389-1397. PubMed ID: 33052738
[No Abstract] [Full Text] [Related]
9. Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.
Mnatzakanian GN; Shinagare AB; Sahni VA; Hirsch MS; Silverman SG
Abdom Radiol (NY); 2016 Nov; 41(11):2187-2195. PubMed ID: 27383741
[TBL] [Abstract][Full Text] [Related]
10. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of microvascular density and clinicopathological factors in different subtypes of renal cell carcinoma].
Zhang YH; Yang Q; Cui W; Liu YX; Liu SX; Yao X
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):117-22. PubMed ID: 20403242
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses.
Dai C; Cao Y; Jia Y; Ding Y; Sheng R; Zeng M; Zhou J
Abdom Radiol (NY); 2018 Mar; 43(3):672-678. PubMed ID: 28721478
[TBL] [Abstract][Full Text] [Related]
13. Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging.
Udare A; Walker D; Krishna S; Chatelain R; McInnes MD; Flood TA; Schieda N
Eur Radiol; 2020 Apr; 30(4):2091-2102. PubMed ID: 31858204
[TBL] [Abstract][Full Text] [Related]
14. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
[TBL] [Abstract][Full Text] [Related]
15. Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.
Xue LY; Lu Q; Huang BJ; Li Z; Li CX; Wen JX; Wang WP
Eur J Radiol; 2015 Oct; 84(10):1849-56. PubMed ID: 26149528
[TBL] [Abstract][Full Text] [Related]
16. Relative Computed Tomography (CT) Enhancement Value for the Assessment of Microvascular Architecture in Renal Cell Carcinoma.
Ouyang AM; Wei ZL; Su XY; Li K; Zhao D; Yu DX; Ma XX
Med Sci Monit; 2017 Jul; 23():3706-3714. PubMed ID: 28757600
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.
Reiner CS; Roessle M; Thiesler T; Eberli D; Klotz E; Frauenfelder T; Sulser T; Moch H; Alkadhi H
Invest Radiol; 2013 Apr; 48(4):183-91. PubMed ID: 23328912
[TBL] [Abstract][Full Text] [Related]
18. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.
Chandarana H; Rosenkrantz AB; Mussi TC; Kim S; Ahmad AA; Raj SD; McMenamy J; Melamed J; Babb JS; Kiefer B; Kiraly AP
Radiology; 2012 Dec; 265(3):790-8. PubMed ID: 23175544
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
20. Study of 320-slice dynamic volume CT perfusion in different pathologic types of kidney tumor: preliminary results.
Chen C; Liu Q; Hao Q; Xu B; Ma C; Zhang H; Shen Q; Lu J
PLoS One; 2014; 9(1):e85522. PubMed ID: 24465588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
